Alessio Bevilacqua

7PUBLICATIONS
104CO-AUTHORS
Haematological tumoursPredictive and prognostic markersEvolution of developmental systemsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 04, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki

|Jul 16, 2025
Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophages.

Xiaoyun Li, Sofie Hedlund Møller, Jaeoh Park

|Aug 23, 2024
PPARβ/δ-orchestrated metabolic reprogramming supports the formation and maintenance of memory CD8+ T cells.

Alessio Bevilacqua, Fabien Franco, Ya-Ting Lu

|Sep 22, 2023
Regulatory circuits of mitophagy restrict distinct modes of cell death during memory CD8+ T cell formation.

Fabien Franco, Alessio Bevilacqua, Ruey-Mei Wu

|Sep 21, 2023
Reductive carboxylation epigenetically instructs T cell differentiation.

Alison Jaccard, Tania Wyss, Noelia Maldonado-Pérez

|Jul 01, 2022
Androgen effects cause sex-biased impairment of CD8+ T cell antitumor activity.

Alessio Bevilacqua, Ping-Chih Ho

Pageof 2